Another Milestone for Vivesto’s Paccal Vet: Limited Market Classification in the EU for Canine Splenic Hemangiosarcoma
This classification may allow faster regulatory approval in the EU and protect Paccal Vet from generic competition for 10 years.
top of page
Nov 1
How a 13-year-old Dog with Hemangiosarcoma is Thriving Thanks to Current Clinical Trials
The University of Minnesota Veterinary Medical Center shared the success story of one of his fur patients
Apr 12, 2023
Ethos Discovery Battling to Switch Euthanasia for Splenectomy On Larger, Older Dogs with Hemangiosarcoma
Ethos Discovery is Pushing a Different Treatment Over Old Beliefs
bottom of page